Drug Resistance in Plasmodium

Overview

Journal Nat Rev Microbiol

Specialties Infectious Diseases
Microbiology

Date 2018 Jan 23

PMID 29355852

Citations 152

Authors

Kasturi Haldar

Souvik Bhattacharjee

Innocent Safeukui

Affiliations

Soon will be listed here.

Abstract

A marked decrease in malaria-related deaths worldwide has been attributed to the administration of effective antimalarials against Plasmodium falciparum, in particular, artemisinin-based combination therapies (ACTs). Increasingly, ACTs are also used to treat Plasmodium vivax, the second major human malaria parasite. However, resistance to frontline artemisinins and partner drugs is now causing the failure of P. falciparum ACTs in southeast Asia. In this Review, we discuss our current knowledge of markers and mechanisms of resistance to artemisinins and ACTs. In particular, we describe the identification of mutations in the propeller domains of Kelch 13 as the primary marker for artemisinin resistance in P. falciparum and explore two major mechanisms of resistance that have been independently proposed: the activation of the unfolded protein response and proteostatic dysregulation of parasite phosphatidylinositol 3- kinase. We emphasize the continuing challenges and the imminent need to understand mechanisms of resistance to improve parasite detection strategies, develop new combinations to eliminate resistant parasites and prevent their global spread.

Citing Articles

Antiprotozoal Aminosteroids from .

Schafer L, Cal M, Kaiser M, Maser P, Schmidt T Molecules. 2025; 30(5).

PMID: 40076324 PMC: 11902257. DOI: 10.3390/molecules30051093.

Pfs16: A Key Parasitophorous Vacuole Membrane Protein Crucial for Malaria Parasite Development and Transmission.

Shabani S, Serbus L Protein J. 2025; .

PMID: 39979562 DOI: 10.1007/s10930-025-10260-1.

From Traditional Amazon Use to Food Applications: Seed Extracts as a Triad of Antiproliferative Effect, Oxidative Defense, and Antimalarial Activity.

Crispim M, Silva T, Lima A, Cruz L, Bento N, Cruz T Foods. 2025; 14(3).

PMID: 39942060 PMC: 11817332. DOI: 10.3390/foods14030467.

transcription factor AP2-06B is mutated at high frequency in Southeast Asia but does not associate with drug resistance.

Shi Q, Wang C, Yang W, Ma X, Tang J, Zhang J Front Cell Infect Microbiol. 2025; 14():1521152.

PMID: 39835275 PMC: 11744005. DOI: 10.3389/fcimb.2024.1521152.

Antiplasmodial and Insecticidal Activities of Third-Generation Ivermectin Hybrids.

Parth , Santana S, Rola C, Oliveira C, Prudencio M, Singh K J Med Chem. 2024; 67(22):20224-20241.

PMID: 39505355 PMC: 11613448. DOI: 10.1021/acs.jmedchem.4c01606.

References

Ashley E, Dhorda M, Fairhurst R, Amaratunga C, Lim P, Suon S . Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014; 371(5):411-23. PMC: 4143591. DOI: 10.1056/NEJMoa1314981. View

Price R, von Seidlein L, Valecha N, Nosten F, Baird J, White N . Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis. Lancet Infect Dis. 2014; 14(10):982-91. PMC: 4178238. DOI: 10.1016/S1473-3099(14)70855-2. View

Sa J, Twu O, Hayton K, Reyes S, Fay M, Ringwald P . Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine. Proc Natl Acad Sci U S A. 2009; 106(45):18883-9. PMC: 2771746. DOI: 10.1073/pnas.0911317106. View

Dondorp A, Nosten F, Yi P, Das D, Phyo A, Tarning J . Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009; 361(5):455-67. PMC: 3495232. DOI: 10.1056/NEJMoa0808859. View

Srivastava I, Vaidya A . A mechanism for the synergistic antimalarial action of atovaquone and proguanil. Antimicrob Agents Chemother. 1999; 43(6):1334-9. PMC: 89274. DOI: 10.1128/AAC.43.6.1334. View

Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V . Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda. J Infect Dis. 2017; 215(4):631-635. PMC: 5853976. DOI: 10.1093/infdis/jiw614. View

Korenromp E, Williams B, Gouws E, Dye C, Snow R . Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy. Lancet Infect Dis. 2003; 3(6):349-58. DOI: 10.1016/s1473-3099(03)00657-1. View

Cheeseman I, Miller B, Nair S, Nkhoma S, Tan A, Tan J . A major genome region underlying artemisinin resistance in malaria. Science. 2012; 336(6077):79-82. PMC: 3355473. DOI: 10.1126/science.1215966. View

Jensen M, Mehlhorn H . Seventy-five years of Resochin in the fight against malaria. Parasitol Res. 2009; 105(3):609-27. DOI: 10.1007/s00436-009-1524-8. View

10.

Price R, Tjitra E, Guerra C, Yeung S, White N, Anstey N . Vivax malaria: neglected and not benign. Am J Trop Med Hyg. 2008; 77(6 Suppl):79-87. PMC: 2653940. View

11.

McCarthy J, Lotharius J, Ruckle T, Chalon S, Phillips M, Elliott S . Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study. Lancet Infect Dis. 2017; 17(6):626-635. PMC: 5446412. DOI: 10.1016/S1473-3099(17)30171-8. View

12.

Goodman C, Buchanan H, McFadden G . Is the Mitochondrion a Good Malaria Drug Target?. Trends Parasitol. 2016; 33(3):185-193. DOI: 10.1016/j.pt.2016.10.002. View

13.

Li H, ODonoghue A, van der Linden W, Xie S, Yoo E, Foe I . Structure- and function-based design of Plasmodium-selective proteasome inhibitors. Nature. 2016; 530(7589):233-6. PMC: 4755332. DOI: 10.1038/nature16936. View

14.

Sisowath C, Ferreira P, Bustamante L, Dahlstrom S, Martensson A, Bjorkman A . The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa. Trop Med Int Health. 2007; 12(6):736-42. DOI: 10.1111/j.1365-3156.2007.01843.x. View

15.

Amaratunga C, Lim P, Suon S, Sreng S, Mao S, Sopha C . Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. Lancet Infect Dis. 2016; 16(3):357-65. PMC: 4792715. DOI: 10.1016/S1473-3099(15)00487-9. View

16.

Baragana B, Hallyburton I, Lee M, Norcross N, Grimaldi R, Otto T . A novel multiple-stage antimalarial agent that inhibits protein synthesis. Nature. 2015; 522(7556):315-20. PMC: 4700930. DOI: 10.1038/nature14451. View

17.

Costa G, Amaral L, Fontes C, Carvalho L, Brito C, Nobrega de Sousa T . Assessment of copy number variation in genes related to drug resistance in Plasmodium vivax and Plasmodium falciparum isolates from the Brazilian Amazon and a systematic review of the literature. Malar J. 2017; 16(1):152. PMC: 5395969. DOI: 10.1186/s12936-017-1806-z. View

18.

Noedl H, Se Y, Schaecher K, Smith B, Socheat D, Fukuda M . Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008; 359(24):2619-20. DOI: 10.1056/NEJMc0805011. View

19.

Wang J, Zhang C, Chia W, Loh C, Li Z, Lee Y . Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum. Nat Commun. 2015; 6:10111. PMC: 4703832. DOI: 10.1038/ncomms10111. View

20.

Phillips M, Burrows J, Manyando C, Hooft van Huijsduijnen R, Van Voorhis W, Wells T . Malaria. Nat Rev Dis Primers. 2017; 3:17050. DOI: 10.1038/nrdp.2017.50. View